Literature DB >> 21271789

The ALS Nutrition/NIPPV Study: design, feasibility, and initial results.

Edward J Kasarskis1, Marta S Mendiondo, Stephen Wells, Maria S Malguizo, Megan Thompson, Margaret Healey, Richard J Kryscio.   

Abstract

Our objective was to investigate the nutritional requirements in ALS and to determine the feasibility of early intervention with NIPPV. Subjects were enrolled into one of two arms. In the nutrition arm, total daily energy expenditure (TDEE) was determined longitudinally over 48 weeks using the Doubly Labeled Water method. In the NIPPV arm, NIPPV was offered at 80% vs. 50% FVC. Additional measurements were obtained in both arms to ultimately formulate equations to predict TDEE and to estimate sample size for a phase III study of early NIPPV. Eighty subjects were enrolled in the nutrition arm and 73 in the NIPPV arm. Baseline characteristics of the participants are described. TDEE was available for 80 subjects in 249 independent determinations during disease progression. Other variables were measured simultaneously for future modeling of ALS-specific equations to predict TDEE. In the NIPPV arm, rates of progression to the criteria for NIPPV intervention (80% or 50% predicted FVC) were computed. Additional factors were obtained longitudinally to develop indices of early ventilatory insufficiency. The results of this study will allow us to model equations to predict the energy requirements in ALS and to plan a study of early intervention with NIPPV.

Entities:  

Mesh:

Year:  2011        PMID: 21271789     DOI: 10.3109/17482968.2010.515225

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler        ISSN: 1471-180X


  6 in total

Review 1.  Complementary and Alternative Therapies in Amyotrophic Lateral Sclerosis.

Authors:  Richard S Bedlack; Nanette Joyce; Gregory T Carter; Sabrina Paganoni; Chafic Karam
Journal:  Neurol Clin       Date:  2015-09-08       Impact factor: 3.806

2.  Relationship of creatine kinase to body composition, disease state, and longevity in ALS.

Authors:  Summer B Gibson; Edward J Kasarskis; Nan Hu; Stefan-M Pulst; Marta S Mendiondo; Dwight E Matthews; Hiroshi Mitsumoto; Rup Tandan; Zachary Simmons; Richard J Kryscio; Mark B Bromberg
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2015-08-27       Impact factor: 4.092

3.  Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial.

Authors:  Anne-Marie Wills; Jane Hubbard; Eric A Macklin; Jonathan Glass; Rup Tandan; Ericka P Simpson; Benjamin Brooks; Deborah Gelinas; Hiroshi Mitsumoto; Tahseen Mozaffar; Gregory P Hanes; Shafeeq S Ladha; Terry Heiman-Patterson; Jonathan Katz; Jau-Shin Lou; Katy Mahoney; Daniela Grasso; Robert Lawson; Hong Yu; Merit Cudkowicz
Journal:  Lancet       Date:  2014-02-28       Impact factor: 79.321

4.  Estimating daily energy expenditure in individuals with amyotrophic lateral sclerosis.

Authors:  Edward J Kasarskis; Marta S Mendiondo; Dwight E Matthews; Hiroshi Mitsumoto; Rup Tandan; Zachary Simmons; Mark B Bromberg; Richard J Kryscio
Journal:  Am J Clin Nutr       Date:  2014-02-12       Impact factor: 7.045

5.  Patient-reported problematic symptoms in an ALS treatment trial.

Authors:  Divisha Raheja; Helen E Stephens; Erik Lehman; Susan Walsh; Chengwu Yang; Zachary Simmons
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2016-01-29       Impact factor: 4.092

6.  Body composition in amyotrophic lateral sclerosis subjects and its effect on disease progression and survival.

Authors:  Rup Tandan; Evan A Levy; Diantha B Howard; John Hiser; Nathan Kokinda; Swatee Dey; Edward J Kasarskis
Journal:  Am J Clin Nutr       Date:  2022-05-01       Impact factor: 8.472

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.